Published in Cancer Weekly, April 15th, 2008
"A better understanding of the Immunology of cancer has led to novel strategies for vaccine delivery, including the use of immunogenic adjuvant agents, genetic modification of tumor cells to produce cytokines, viral vectors, and the use of antigen-presenting cells. A number of these strategies have been studied in clinical trials for lung cancer," wrote J. Kim and colleagues, University of California.
The researchers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2008-04-15)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.